Transaction DateRecipientSharesTypePriceValue
15th September 2020Advisors Llc Perceptive2,911,764Open or private purchase$4.25$12,374,997.00
14th September 2020Advisors Llc Perceptive1,800,000Open or private purchase$11.00$19,800,000.00
14th September 2020Advisors Llc Perceptive400,000Open or private purchase$40.00$16,000,000.00
10th September 2020Advisors Llc Perceptive200,000Open or private purchase$11.24$2,248,000.00
7th August 2020Augustine Lawlor2,090Grant/award etc.$0.00
9th July 2020Advisors Llc Perceptive3,200,000Open or private purchase$4.25$13,600,000.00
1st July 2020Augustine Lawlor3,673Grant/award etc.$0.00
22nd June 2020Advisors Llc Perceptive1,750,000Open or private purchase$2.00$3,500,000.00
9th June 2020Advisors Llc Perceptive2,702,702Open or private purchase$1.85$4,999,998.70
5th May 2020Advisors Llc Perceptive76,172Payment by withholding$16.00$1,218,752.00
Leap Therapeutics
Leap Therapeutics logo

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01 and TRX518.

Ticker: LPTX
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1509745
Employees: 25
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags